You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Last Updated: February 21, 2020

DrugPatentWatch Database Preview


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACTAVIS MID ATLANTIC, and what generic and branded alternatives to ACTAVIS MID ATLANTIC drugs are available?

ACTAVIS MID ATLANTIC has sixty-two approved drugs.


Drugs and US Patents for ACTAVIS MID ATLANTIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 086833-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic LEVETIRACETAM levetiracetam SOLUTION;ORAL 078976-001 Jan 15, 2009 AA RX No No   Start Trial   Start Trial
Actavis Mid Atlantic ENULOSE lactulose SOLUTION;ORAL, RECTAL 071548-001 Aug 15, 1988 AA RX No Yes   Start Trial   Start Trial
Actavis Mid Atlantic FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride SOLUTION;ORAL 075690-001 Jan 31, 2002 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic BETAMETHASONE DIPROPIONATE betamethasone dipropionate LOTION;TOPICAL 070281-001 Jul 31, 1985 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.